The collaboration embeds DrugBank’s curated database—which spans two decades of drug targets, clinical trials, and disease relationships—into the Copilot interface. Users working in Word, Excel, or PowerPoint can now query the graph to perform target identification, safety checks, or competitive landscaping without switching between siloed platforms. The system ensures that every AI-generated response is linked to its primary source, allowing researchers to verify findings for regulatory or executive review.

Lisa Downey, CEO of DrugBank, emphasized that the shift from probabilistic output to deterministic retrieval is critical for scientific workflows. Because the plugin pulls from a versioned knowledge graph, the same query consistently returns identical data, providing the reliability required for pharmaceutical decision-making. Microsoft’s Chantrelle Nielsen noted that grounding Copilot in industry-specific, curated datasets reduces the friction of manual data reconciliation. The plugin, which maps information across 20 industry ontologies, is currently available on the Microsoft Marketplace for enterprises looking to standardize their R&D intelligence.